Is INmune Bio, Inc. (INMB) a Buy, Sell, or Hold?
INmune Bio, Inc.
NASDAQ:INMB
$2.02 USD
$0.16 (8.6%)
- Volume
- 1.04M
- Average Volume
- 707.02K
- Market Capitalization
- $53.7M
- P/E Ratio
- -1.20
- Dividend Yield
- 0.00%
- Price Target
- $22.00
- Year High
- $3.24
- Year Low
- $1.09
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.24
INMB vs. The Competition
| Properties | INMB | ALGS | BRNS | CVM |
|---|---|---|---|---|
| Market Cap | $53.7M | $37.78M | $25.01M | $7.9M |
| Shares Outstanding | $26.59M | $6.19M | $40.85M | $6.87M |
| P/E Ratio | -1.2 | -0.7 | -0.47 | -0.33 |
| EPS | -1.56 | -8.68 | -1.28 | -2.79 |
| Day Low | 1.8207 | 5.97 | 0.6122 | 1.135 |
| Day high | 2.08 | 6.45 | 0.632 | 1.235 |
| Year Low | 1.09 | 4.8 | 0.512 | 0.89 |
| Year High | 3.244 | 13.689 | 2.92 | 13.48 |
| Average Price 50 | 1.4663 | 5.7417 | 0.67376 | 1.3716 |
| Average Price 200 | 1.55578 | 7.74198 | 0.77959 | 4.7225 |
| Volume | 1.04M | 102.51K | 26663 | 321.73K |
| Average Volume | - | - | - | - |